Latest filing published 01 May 2026 for Merck & Co., Inc., €196k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Betty D. Larson across 5 companies, led by Merck & Co., Inc., Becton Dickinson & Co and GE HealthCare Technologies Inc. Between 10 February 2016 and 30 April 2026, the trades on record add up to 14 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 1 May 2026, reports a share grant of €486k in Merck & Co., Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations